Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease
- 23 May 2009
- Vol. 27 (Suppl 2) , B117-B125
- https://doi.org/10.1016/j.vaccine.2009.04.066
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective ActivityClinical and Vaccine Immunology, 2009
- Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit SeraInfection and Immunity, 2009
- Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37Infection and Immunity, 2009
- Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding ProteinInfection and Immunity, 2008
- Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein VaccinesInfection and Immunity, 2008
- Vaccine-Induced Opsonophagocytic Immunity to Neisseria meningitidis Group BClinical and Vaccine Immunology, 2008
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal AntibodyClinical and Vaccine Immunology, 2007
- Seroprevalence of Bactericidal and Anti-Outer Membrane Vesicle Antibodies to Neisseria meningitidis Group B in EnglandClinical and Vaccine Immunology, 2007
- Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvacInfection and Immunity, 2006